102 related articles for article (PubMed ID: 1530674)
1. Cardiovascular effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitropheny l) octyl ester.
Hojo M; Teramoto N; Hata H; Katayama O; Tatsumi H; Shibata S
Arzneimittelforschung; 1992 May; 42(5):621-8. PubMed ID: 1530674
[TBL] [Abstract][Full Text] [Related]
2. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S
Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721
[TBL] [Abstract][Full Text] [Related]
4. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
[TBL] [Abstract][Full Text] [Related]
5. Acute antihypertensive effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)-carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitrophen yl) octyl ester on conscious spontaneously hypertensive rats and renal hypertensive rats.
Hojo M; Tanaka Y; Katayama O; Teramoto N
Arzneimittelforschung; 1993 Aug; 43(8):847-51. PubMed ID: 8216440
[TBL] [Abstract][Full Text] [Related]
6. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs.
Nishikibe M; Nagura J; Kamei K; Fukuroda T
Arch Int Pharmacodyn Ther; 1988; 291():7-20. PubMed ID: 3365068
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
Mori T; Nakayama N; Ohura M; Ikezono K; Kinoshita S; Kamata M; Hosokawa T; Yamashita S; Yabuuchi Y
Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415
[TBL] [Abstract][Full Text] [Related]
9. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
10. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
Pruneau D; Roy F; Brown NL
Therapie; 1989; 44(3):203-8. PubMed ID: 2781506
[TBL] [Abstract][Full Text] [Related]
11. Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs.
Sakanashi M; Noguchi K; Kato T; Sunagawa R; Nagamine F; Nakasone J
Arzneimittelforschung; 1986 Dec; 36(12):1736-9. PubMed ID: 3566835
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
Yamaura T; Kase N; Kita H; Uematsu T
Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
[TBL] [Abstract][Full Text] [Related]
14. Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs.
Nakaya H; Kanno M
Arzneimittelforschung; 1982; 32(6):626-9. PubMed ID: 7202368
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of a new 1,5-benzothiazepine calcium antagonist in anesthetized dogs.
Murata S; Kikkawa K; Yabana H; Nagao T
Arzneimittelforschung; 1988 Apr; 38(4):521-5. PubMed ID: 3401267
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs.
Sakanashi M; Noguchi K; Miyamoto Y; Kato T; Nagamine F; Yu WY; Higuchi M; Nakasone J
Arch Int Pharmacodyn Ther; 1988; 294():159-74. PubMed ID: 2976588
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of a new dihydropyridine calcium antagonist.
Kimura Y; Fukui H; Tanaka M; Okamoto M; Miura A; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1336-44. PubMed ID: 3790183
[TBL] [Abstract][Full Text] [Related]
18. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
[TBL] [Abstract][Full Text] [Related]
19. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effect of the new dihydropyridine calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5-nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedica rbo xylate hydrochloride in dogs.
Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
Arzneimittelforschung; 1992 Apr; 42(4):513-8. PubMed ID: 1642675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
